Validation overview and significance MCQs With Answer

Validation Overview and Significance MCQs With Answer

Validation is the backbone of modern pharmaceutics, ensuring that processes, methods, equipment, and systems consistently perform as intended and produce products of assured quality. For M. Pharm students, a strong grasp of validation principles—spanning process, cleaning, analytical, utility, and computerized systems—is essential to meet regulatory expectations and protect patient safety. This quiz dives into the lifecycle approach, documentation (VMP, protocols, reports), acceptance criteria, statistical concepts, and evolving regulatory trends (e.g., HBEL/PDE-based limits, continued process verification). The questions are designed to reinforce critical thinking, link theory to practice, and prepare you for audits, quality roles, and research-driven decision-making in pharma development and manufacturing.

Q1. Which statement best defines validation in pharmaceutical manufacturing?

  • Documented evidence that a process will consistently produce a product meeting predetermined specifications and quality attributes
  • A one-time test demonstrating that a batch meets specifications
  • A regulatory approval that replaces in-process controls
  • An internal quality review conducted after product launch

Correct Answer: Documented evidence that a process will consistently produce a product meeting predetermined specifications and quality attributes

Q2. The primary objective of process validation is to ensure:

  • Elimination of the need for routine quality control testing
  • Consistency and reproducibility of product quality across the lifecycle
  • Reduction in manufacturing costs regardless of risk
  • Compliance only during regulatory inspections

Correct Answer: Consistency and reproducibility of product quality across the lifecycle

Q3. Which option correctly lists the three stages of FDA’s process validation lifecycle?

  • Design Verification, Design Qualification, Performance Qualification
  • Process Design, Process Qualification (including PPQ), Continued Process Verification
  • Installation Qualification, Operational Qualification, Performance Qualification
  • Prospective Validation, Concurrent Validation, Retrospective Validation

Correct Answer: Process Design, Process Qualification (including PPQ), Continued Process Verification

Q4. What is the main purpose of a Validation Master Plan (VMP)?

  • To record batch-specific test results
  • To provide a high-level roadmap describing the validation strategy, scope, responsibilities, and schedule
  • To serve as a substitute for individual validation protocols
  • To define marketing strategy and product launch timelines

Correct Answer: To provide a high-level roadmap describing the validation strategy, scope, responsibilities, and schedule

Q5. Current best practice for setting cleaning validation acceptance limits prioritizes which basis?

  • 10 ppm of previous product in next product
  • 1/1000th of minimum therapeutic dose
  • Health-based exposure limits (HBEL), e.g., PDE-based calculations
  • Visual cleanliness only

Correct Answer: Health-based exposure limits (HBEL), e.g., PDE-based calculations

Q6. Which qualification activity verifies that equipment is installed according to approved design specifications and manufacturer recommendations?

  • Design Qualification (DQ)
  • Installation Qualification (IQ)
  • Operational Qualification (OQ)
  • Performance Qualification (PQ)

Correct Answer: Installation Qualification (IQ)

Q7. Which of the following is NOT typically an element of a Validation Master Plan?

  • Validation policy, scope, and responsibilities
  • Inventory of systems/processes requiring validation
  • Validation schedule and change control linkage
  • Batch Manufacturing Record for a specific product

Correct Answer: Batch Manufacturing Record for a specific product

Q8. Selecting a product with highest toxicity, lowest solubility, highest potency, and largest batch size for cleaning validation is an example of:

  • Bracketing
  • Worst-case approach
  • Matrixing
  • Retrospective validation

Correct Answer: Worst-case approach

Q9. In analytical method validation per ICH, which parameter evaluates the ability of the method to remain unaffected by small deliberate variations?

  • Specificity
  • Robustness
  • Accuracy
  • Ruggedness only

Correct Answer: Robustness

Q10. Which statement about prospective, concurrent, and retrospective validation is most accurate?

  • Prospective validation is performed after routine production has started
  • Concurrent validation collects data during routine production and release
  • Retrospective validation is preferred by regulators for new products
  • Prospective validation uses only market complaints as data

Correct Answer: Concurrent validation collects data during routine production and release

Q11. Which combination best differentiates swab and rinse sampling in cleaning validation?

  • Swab for inaccessible areas; rinse for flat surfaces only
  • Swab quantifies residues on defined surface areas; rinse captures residues from system internals and hard-to-reach areas
  • Swab collects volatile residues; rinse collects non-volatile residues
  • Swab is qualitative; rinse is always quantitative

Correct Answer: Swab quantifies residues on defined surface areas; rinse captures residues from system internals and hard-to-reach areas

Q12. Which scenario best suits bracketing during validation?

  • Validating only the mid-strength assuming extremes perform similarly
  • Validating the lowest and highest strengths or equipment sizes, assuming intermediates are represented
  • Validating all strengths and sizes independently without reduction
  • Using historical data only for all strengths

Correct Answer: Validating the lowest and highest strengths or equipment sizes, assuming intermediates are represented

Q13. In process validation, identification of Critical Process Parameters (CPPs) primarily relies on:

  • Random selection of operating parameters
  • Risk assessment linking parameters to CQAs, supported by DoE and prior knowledge
  • Only vendor recommendations
  • Visual inspection of equipment

Correct Answer: Risk assessment linking parameters to CQAs, supported by DoE and prior knowledge

Q14. What is the best current view on the number of PPQ (process performance qualification) batches?

  • Always three batches regardless of risk or knowledge
  • Determined by risk, process understanding, variability, and control strategy; often three but may be more or fewer
  • One batch is sufficient if tested extensively
  • Ten batches are mandatory per global regulations

Correct Answer: Determined by risk, process understanding, variability, and control strategy; often three but may be more or fewer

Q15. Which feature is essential for data integrity in validated computerized systems under 21 CFR Part 11?

  • Editable audit trails to correct operator errors
  • Audit trails that capture who did what and when, including create/modify/delete events with timestamps
  • Shared logins to simplify user management
  • Disabling electronic signatures to avoid complexity

Correct Answer: Audit trails that capture who did what and when, including create/modify/delete events with timestamps

Q16. ALCOA+ in data integrity expands to:

  • Attributable, Logical, Calculated, Original, Accurate plus Correct, Efficient
  • Attributable, Legible, Contemporaneous, Original, Accurate plus Complete, Consistent, Enduring, Available
  • Applicable, Legal, Controlled, Original, Audited plus Classified, Encrypted
  • Assigned, Listed, Confirmed, Official, Approved plus Central, Enabled

Correct Answer: Attributable, Legible, Contemporaneous, Original, Accurate plus Complete, Consistent, Enduring, Available

Q17. Which change most clearly triggers the need for revalidation or additional qualification?

  • Change in document font in SOPs
  • Relocation or major modification of critical equipment impacting CPPs
  • Updating the company logo on validation reports
  • Reordering the same raw material lot

Correct Answer: Relocation or major modification of critical equipment impacting CPPs

Q18. Hold-time studies in validation are conducted to:

  • Determine marketing shelf-life
  • Verify that in-process materials and cleaned equipment remain within validated state over defined dirty and clean hold times
  • Replace environmental monitoring
  • Avoid the need for cleaning validation

Correct Answer: Verify that in-process materials and cleaned equipment remain within validated state over defined dirty and clean hold times

Q19. Continued Process Verification (CPV) primarily ensures:

  • Initial qualification of equipment only
  • Ongoing assurance that the process remains in a state of control using routine data and statistical monitoring
  • That validation can be terminated after PPQ
  • That only end-product testing is required for release

Correct Answer: Ongoing assurance that the process remains in a state of control using routine data and statistical monitoring

Q20. Interpreting process capability, a Cpk value significantly below 1.33 typically indicates:

  • A highly capable process with broad compliance margin
  • Process may be incapable of meeting specifications consistently; further optimization or tighter controls are needed
  • No impact on validation status
  • That specifications should be widened as the first option

Correct Answer: Process may be incapable of meeting specifications consistently; further optimization or tighter controls are needed

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators